INTERCEPT PHARMACEUTICALS, INC. Business Finance Contracts & Agreements

49 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Supplemental Indenture, dated as of November 8, 2023, between Intercept Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Third Supplemental Indenture, dated as of November 8, 2023, between Intercept Pharmaceuticals, Inc., and U.S. Bank Trust Company, National Association
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Form of Exchange Agreement for the 2026 Notes
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Form of Stock Option Grant Notice and Agreement for Directors
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Form of Stock Option Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Amendment to Share Purchase Agreement, dated July 1, 2022, between ICPT Inc. and Mercury Pharma
Share Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Amendment to Safety Data Exchange Agreement, dated July 1, 2022, between ICPT Inc. and Mercury Pharma
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2022
Safety Data Exchange Agreement, dated May 5, 2022, between ICPT Inc. and Mercury Pharma
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Share Purchase Agreement, dated May 5, 2022, between Intercept Pharmaceuticals, Inc. (ICPT Inc.) as seller and Mercury Pharma Group Limited (Mercury Pharma) as purchaser
Share Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NJ
2022
Security Agreement, dated as of August 17, 2021, among Intercept Pharmaceuticals, Inc., the Guarantors that may from time to time be a party thereto and U.S. Bank National...
Security Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2021
First Supplemental Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee and as collateral agent
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2021
Indenture, dated as of August 17, 2021, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as trustee
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2021
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Form of Stock Option Grant Notice and Agreement for Directors
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Form of Stock Option Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2020
Second Supplemental Indenture, dated as of May 14, 2019, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00%...
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2019
Securities Purchase Agreement, dated May 8, 2019, between Intercept Pharmaceuticals, Inc. and Samsara BioCapital, L.P
Purchase Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies...
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,...
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Form of Restricted Stock Unit Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Form of Stock Option Grant Notice and Agreement for Employees and Consultants
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Securities Purchase Agreement, dated April 4, 2018, between Intercept Pharmaceuticals, Inc. and the purchasers named therein
Purchase Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Underwriting Agreement, dated April 5, 2018, between Intercept Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2018
INTERCEPT PHARMACEUTICALS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of July 6, 2016 to Indenture for Senior Debt Securities Dated...
Note Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2016
INTERCEPTPharmaceuticals, Inc. and U.S.Bank National Association, as Trustee INDENTURE Dated as of July 6, 2016 SENIOR DEBT SECURITIES
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2016
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) $400,000,000 3.25% Convertible Senior Notes due 2023 UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2016
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,200,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2015
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2015
INTERCEPTPHARMACEUTICALS, INC.4 (a Delawarecorporation) 1,000,000Shares of Common Stock UNDERWRITINGAGREEMENT
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2014
*** OMITTED AND FILED SEPARATELY WITHTHE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER17 C.F.R. SECTION 240.24b-2 AMENDMENT NO. 4 TO RESEARCH AND...
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2014
*** OMITTED AND FILED SEPARATELY WITHTHE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER17 C.F.R. SECTION 240.24b-2 AMENDMENT NO. 4 TO CONSULTING AND...
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2014
*** OMITTED AND FILED SEPARATELY WITHTHE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED UNDER17 C.F.R. SECTION 240.24b-2 AMENDMENT N°4 TO PRODUCT RESEARCH,...
Exchange Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
2014
INTERCEPTPHARMACEUTICALS, INC. (a Delawarecorporation) [________]Shares of Common Stock UNDERWRITINGAGREEMENT
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2013
INTERCEPT PHARMACEUTICALS, INC. Restricted Stock Unit Award Grant Noticefor Employees and Consultants Restricted Stock Unit Award Grant underthe Company’s 2012 EquityIncentive...
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2012
INTERCEPT PHARMACEUTICALS, INC. Restricted Stock Unit Award Grant Noticefor Directors Restricted Stock Unit Award Grant underthe Company’s 2012 EquityIncentive Plan
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2012
INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) [l]Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2012
INTERCEPT PHARMACEUTICALS, INC. SERIES C CONVERTIBLE PREFERRED STOCK PURCHASEAGREEMENT* Dated as of August 9, 2012
Stock Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
DE
2012